The Natural Anticancer Compounds Rocaglamides Inhibit the Raf-MEK-ERK Pathway by Targeting Prohibitin 1 and 2
Gernot Polier(German Cancer Research Center), Min Li‐Weber(German Cancer Research Center), Nigel Ribeiro(Centre National de la Recherche Scientifique), Ottmar Janßen(Christian-Albrechts-Universität zu Kiel), Rebecca Köhler(German Cancer Research Center), Wolfgang W. Müller(German Cancer Research Center), Frédéric Thuaud(Centre National de la Recherche Scientifique), Matthias Leippe(Hochschule für Angewandte Wissenschaften Kiel), Peter H. Krammer(Slovak Academy of Sciences), Peter Proksch(Heinrich Heine University Düsseldorf), Hendrik Schmidt(Kiel University), Laurent Désaubry(Centre National de la Recherche Scientifique), Marco Giaisi(German Cancer Research Center), Jennifer Neumann(Heidelberg University), Christoph Gelhaus(Christian-Albrechts-Universität zu Kiel)
Cited by 162
Related Papers
FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex
|Cell|1996|3.1k
Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor.
|The EMBO Journal|1995|2.2k
Death and anti-death: tumour resistance to apoptosis
|Nature reviews. Cancer|2002|2.1k
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
|Science|1989|1.7k
Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
|Nature|1995|1.6k